[HTML][HTML] Adipose tissue distribution, inflammation and its metabolic consequences, including diabetes and cardiovascular disease

A Chait, LJ Den Hartigh - Frontiers in cardiovascular medicine, 2020 - frontiersin.org
Adipose tissue plays essential roles in maintaining lipid and glucose homeostasis. To date
several types of adipose tissue have been identified, namely white, brown, and beige, that …

Effect of metformin on all-cause and cardiovascular mortality in patients with coronary artery diseases: a systematic review and an updated meta-analysis

Y Han, H Xie, Y Liu, P Gao, X Yang, Z Shen - Cardiovascular Diabetology, 2019 - Springer
Background Metformin is the most widely prescribed drug to lower glucose and has a
definitive effect on the cardiovascular system. The goal of this systematic review and meta …

Diabetes mellitus, blood glucose and the risk of atrial fibrillation: a systematic review and meta-analysis of cohort studies

D Aune, T Feng, S Schlesinger, I Janszky… - Journal of Diabetes and …, 2018 - Elsevier
Background Diabetes and elevated blood glucose have been associated with increased risk
of atrial fibrillation in a number of epidemiological studies, however, the findings have not …

Effects of metformin in heart failure: From pathophysiological rationale to clinical evidence

T Salvatore, R Galiero, A Caturano, E Vetrano… - Biomolecules, 2021 - mdpi.com
Type 2 diabetes mellitus (T2DM) is a worldwide major health burden and heart failure (HF)
is the most common cardiovascular (CV) complication in affected patients. Therefore …

Association of metformin administration with gut microbiome dysbiosis in healthy volunteers

I Elbere, I Kalnina, I Silamikelis, I Konrade… - PloS one, 2018 - journals.plos.org
Background Metformin is a widely used first-line drug for treatment of type 2 diabetes.
Despite its advantages, metformin has variable therapeutic effects, contraindications, and …

Adipose tissue immunomodulation: a novel therapeutic approach in cardiovascular and metabolic diseases

I AlZaim, SH Hammoud, H Al-Koussa… - Frontiers in …, 2020 - frontiersin.org
Adipose tissue is a critical regulator of systemic metabolism and bodily homeostasis as it
secretes a myriad of adipokines, including inflammatory and anti-inflammatory cytokines. As …

Cardiovascular risk following metformin treatment in patients with type 2 diabetes mellitus: Results from meta-analysis

K Zhang, W Yang, H Dai, Z Deng - Diabetes Research and Clinical Practice, 2020 - Elsevier
Aim Pharmacologic therapy for T2DM has proven benefits in terms of reducing elevated
blood glucose levels and reducing microvascular complications. However, the impact of …

Mechanisms of action of metformin with special reference to cardiovascular protection

AV Zilov, SI Abdelaziz, A AlShammary… - Diabetes/metabolism …, 2019 - Wiley Online Library
Management guidelines continue to identify metformin as initial pharmacologic antidiabetic
therapy of choice for people with type 2 diabetes without contraindications, despite recent …

Metformin use and clinical outcomes among patients with diabetes mellitus with or without heart failure or kidney dysfunction: observations from the SAVOR-TIMI 53 …

BA Bergmark, DL Bhatt, DK McGuire, A Cahn… - Circulation, 2019 - Am Heart Assoc
Background: Metformin is first-line therapy for type 2 diabetes mellitus, although its effects on
the cardiovascular system are unproved. Methods: In this post hoc analysis, patients in …

Exploring the dual character of metformin in Alzheimer's disease

P Ning, A Luo, X Mu, Y Xu, T Li - Neuropharmacology, 2022 - Elsevier
Alzheimer's disease (AD) is the most common neurodegenerative disease, which results in
dementia typically in the elderly. The disease is mainly characterized by the deposition of …